Global Attention Deficit Hyperactivity Disorder (ADHD) Market Analysis and Forecast 2024-2030

Global Attention Deficit Hyperactivity Disorder (ADHD) Market Analysis and Forecast 2024-2030


Summary

According to APO Research, The global Attention Deficit Hyperactivity Disorder (ADHD) market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Attention Deficit Hyperactivity Disorder (ADHD) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Attention Deficit Hyperactivity Disorder (ADHD) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Attention Deficit Hyperactivity Disorder (ADHD) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Attention Deficit Hyperactivity Disorder (ADHD) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global companies of Attention Deficit Hyperactivity Disorder (ADHD) include Takeda, Johnson & Johnson, Novartis, Eli Lilly, Tris Pharma, Neos Therapeutics, Mallinckrodt, Amneal Pharmaceuticals and Noven Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Attention Deficit Hyperactivity Disorder (ADHD), market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Attention Deficit Hyperactivity Disorder (ADHD), also provides the revenue of main regions and countries. Of the upcoming market potential for Attention Deficit Hyperactivity Disorder (ADHD), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Attention Deficit Hyperactivity Disorder (ADHD) revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Attention Deficit Hyperactivity Disorder (ADHD) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Attention Deficit Hyperactivity Disorder (ADHD) revenue, projected growth trends, production technology, application and end-user industry.

Attention Deficit Hyperactivity Disorder (ADHD) segment by Company

Takeda
Johnson & Johnson
Novartis
Eli Lilly
Tris Pharma
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma
CTFH
Attention Deficit Hyperactivity Disorder (ADHD) segment by Type

Stimulant
Non-stimulant
Attention Deficit Hyperactivity Disorder (ADHD) segment by Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Attention Deficit Hyperactivity Disorder (ADHD) segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Attention Deficit Hyperactivity Disorder (ADHD) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Attention Deficit Hyperactivity Disorder (ADHD) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Attention Deficit Hyperactivity Disorder (ADHD).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Attention Deficit Hyperactivity Disorder (ADHD) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Attention Deficit Hyperactivity Disorder (ADHD) company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Attention Deficit Hyperactivity Disorder (ADHD) revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Attention Deficit Hyperactivity Disorder (ADHD) Market by Type
1.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Stimulant
1.2.3 Non-stimulant
1.3 Attention Deficit Hyperactivity Disorder (ADHD) Market by Distribution Channel
1.3.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel, 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Attention Deficit Hyperactivity Disorder (ADHD) Market Dynamics
2.1 Attention Deficit Hyperactivity Disorder (ADHD) Industry Trends
2.2 Attention Deficit Hyperactivity Disorder (ADHD) Industry Drivers
2.3 Attention Deficit Hyperactivity Disorder (ADHD) Industry Opportunities and Challenges
2.4 Attention Deficit Hyperactivity Disorder (ADHD) Industry Restraints
3 Global Growth Perspective
3.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Perspective (2019-2030)
3.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Growth Trends by Region
3.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (2019-2024)
3.2.3 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Players
4.1.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Players (2019-2024)
4.1.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Players (2019-2024)
4.1.3 Global Attention Deficit Hyperactivity Disorder (ADHD) Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Attention Deficit Hyperactivity Disorder (ADHD) Key Players Headquarters & Area Served
4.4 Global Attention Deficit Hyperactivity Disorder (ADHD) Players, Product Type & Application
4.5 Global Attention Deficit Hyperactivity Disorder (ADHD) Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market CR5 and HHI
4.6.2 Global Top 5 and 10 Attention Deficit Hyperactivity Disorder (ADHD) Players Market Share by Revenue in 2023
4.6.3 2023 Attention Deficit Hyperactivity Disorder (ADHD) Tier 1, Tier 2, and Tier 3
5 Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type
5.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Type (2019-2030)
5.3 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Type (2019-2030)
6 Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Application
6.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Application (2019-2030)
6.3 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 Takeda
7.1.1 Takeda Comapny Information
7.1.2 Takeda Business Overview
7.1.3 Takeda Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Gross Margin (2019-2024)
7.1.4 Takeda Attention Deficit Hyperactivity Disorder (ADHD) Product Portfolio
7.1.5 Takeda Recent Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Comapny Information
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Gross Margin (2019-2024)
7.2.4 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Product Portfolio
7.2.5 Johnson & Johnson Recent Developments
7.3 Novartis
7.3.1 Novartis Comapny Information
7.3.2 Novartis Business Overview
7.3.3 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Gross Margin (2019-2024)
7.3.4 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Product Portfolio
7.3.5 Novartis Recent Developments
7.4 Eli Lilly
7.4.1 Eli Lilly Comapny Information
7.4.2 Eli Lilly Business Overview
7.4.3 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Gross Margin (2019-2024)
7.4.4 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Product Portfolio
7.4.5 Eli Lilly Recent Developments
7.5 Tris Pharma
7.5.1 Tris Pharma Comapny Information
7.5.2 Tris Pharma Business Overview
7.5.3 Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Gross Margin (2019-2024)
7.5.4 Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Product Portfolio
7.5.5 Tris Pharma Recent Developments
7.6 Neos Therapeutics
7.6.1 Neos Therapeutics Comapny Information
7.6.2 Neos Therapeutics Business Overview
7.6.3 Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Gross Margin (2019-2024)
7.6.4 Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Product Portfolio
7.6.5 Neos Therapeutics Recent Developments
7.7 Mallinckrodt
7.7.1 Mallinckrodt Comapny Information
7.7.2 Mallinckrodt Business Overview
7.7.3 Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Gross Margin (2019-2024)
7.7.4 Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Product Portfolio
7.7.5 Mallinckrodt Recent Developments
7.8 Amneal Pharmaceuticals
7.8.1 Amneal Pharmaceuticals Comapny Information
7.8.2 Amneal Pharmaceuticals Business Overview
7.8.3 Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Gross Margin (2019-2024)
7.8.4 Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product Portfolio
7.8.5 Amneal Pharmaceuticals Recent Developments
7.9 Noven Pharmaceuticals
7.9.1 Noven Pharmaceuticals Comapny Information
7.9.2 Noven Pharmaceuticals Business Overview
7.9.3 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Gross Margin (2019-2024)
7.9.4 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product Portfolio
7.9.5 Noven Pharmaceuticals Recent Developments
7.10 Purdue Parma
7.10.1 Purdue Parma Comapny Information
7.10.2 Purdue Parma Business Overview
7.10.3 Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Gross Margin (2019-2024)
7.10.4 Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Product Portfolio
7.10.5 Purdue Parma Recent Developments
7.11 CTFH
7.11.1 CTFH Comapny Information
7.11.2 CTFH Business Overview
7.11.3 CTFH Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Gross Margin (2019-2024)
7.11.4 CTFH Attention Deficit Hyperactivity Disorder (ADHD) Product Portfolio
7.11.5 CTFH Recent Developments
8 North America
8.1 North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue (2019-2030)
8.2 North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Type (2019-2030)
8.2.1 North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Type (2019-2024)
8.2.2 North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Type (2025-2030)
8.3 North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue Share by Type (2019-2030)
8.4 North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel (2019-2030)
8.4.1 North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel (2019-2024)
8.4.2 North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel (2025-2030)
8.5 North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue Share by Distribution Channel (2019-2030)
8.6 North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Country
8.6.1 North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Country (2019-2024)
8.6.3 North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Country (2025-2030)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue (2019-2030)
9.2 Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Type (2019-2030)
9.2.1 Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Type (2019-2024)
9.2.2 Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Type (2025-2030)
9.3 Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue Share by Type (2019-2030)
9.4 Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel (2019-2030)
9.4.1 Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel (2019-2024)
9.4.2 Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel (2025-2030)
9.5 Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue Share by Distribution Channel (2019-2030)
9.6 Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Country
9.6.1 Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Country (2019-2024)
9.6.3 Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Netherlands
9.6.9 Nordic Countries
10 China
10.1 China Attention Deficit Hyperactivity Disorder (ADHD) Revenue (2019-2030)
10.2 China Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Type (2019-2030)
10.2.1 China Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Type (2019-2024)
10.2.2 China Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Type (2025-2030)
10.3 China Attention Deficit Hyperactivity Disorder (ADHD) Revenue Share by Type (2019-2030)
10.4 China Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel (2019-2030)
10.4.1 China Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel (2019-2024)
10.4.2 China Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel (2025-2030)
10.5 China Attention Deficit Hyperactivity Disorder (ADHD) Revenue Share by Distribution Channel (2019-2030)
11 Asia (Excluding China)
11.1 Asia Attention Deficit Hyperactivity Disorder (ADHD) Revenue (2019-2030)
11.2 Asia Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Type (2019-2030)
11.2.1 Asia Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Type (2019-2024)
11.2.2 Asia Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Type (2025-2030)
11.3 Asia Attention Deficit Hyperactivity Disorder (ADHD) Revenue Share by Type (2019-2030)
11.4 Asia Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel (2019-2030)
11.4.1 Asia Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel (2019-2024)
11.4.2 Asia Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel (2025-2030)
11.5 Asia Attention Deficit Hyperactivity Disorder (ADHD) Revenue Share by Distribution Channel (2019-2030)
11.6 Asia Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Country
11.6.1 Asia Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Country (2019-2024)
11.6.3 Asia Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Attention Deficit Hyperactivity Disorder (ADHD) Revenue (2019-2030)
12.2 MEALA Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Type (2019-2030)
12.2.1 MEALA Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Type (2019-2024)
12.2.2 MEALA Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Type (2025-2030)
12.3 MEALA Attention Deficit Hyperactivity Disorder (ADHD) Revenue Share by Type (2019-2030)
12.4 MEALA Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel (2019-2030)
12.4.1 MEALA Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel (2019-2024)
12.4.2 MEALA Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel (2025-2030)
12.5 MEALA Attention Deficit Hyperactivity Disorder (ADHD) Revenue Share by Distribution Channel (2019-2030)
12.6 MEALA Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Country
12.6.1 MEALA Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Country (2019-2024)
12.6.3 MEALA Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings